Dutchess Opportunity Fund
VC Fund
Boston, United States
Dutchess Opportunity Fund is a VC fund in Boston focused on Cannabis and Health Care. Since 1996, Dutchess has managed over $2 billion in transactional value for companies which span a wide array of sectors. With offices in Boston, New York, London, Beijing and Sao Paulo, Dutchess invests in global investment opportunities. For more than a decade Dutchess has been a global leader in Equity Line Facilities ("ELF") and has transacted in excess of $1.8 billion in such financings. The ELF is a flexible financing structure by which publicly traded companies can raise capital quickly and more efficiently than most traditional offerings.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Dutchess Opportunity Fund invests in
Stages Dutchess Opportunity Fund invests in
Countries Dutchess Opportunity Fund invests in
Investment Focus
Industry
- Cannabis 4 (50%)
- Health Care 3 (38%)
- Manufacturing 3 (38%)
- Mobile 2 (25%)
- Medical 2 (25%)
Stage
- Seed 3 (38%)
- Series A 2 (25%)
- Post-IPO Debt 1 (13%)
- Post-IPO Equity 1 (13%)
- Venture - Series Unknown 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CampusTap provides private career networking and mentoring communities to help students and alumni pursue meaningful careers. With CampusTap, you can recruit alumni for diverse mentoring opportunities, easily match them to students and alumni with similar professional interests, and measure engagement. | $500K / Seed / Jan 05, 2015 | ||
| From increased arousal & pleasure to sexual & menstrual comfort, our products solve real challenges and deliver meaningful results. | Seed / Jun 01, 2014 | ||
| At Dixie, it is our mission to be the trusted source for innovative, safe, effective, and delicious cannabis products — leading the industry through research, education, and advocacy.They handcraft delicious, refreshing, feel-good treats, and indulgences made with pure, premium cannabis. Their products are innovative, safe, effective, and madewith a process and care they are proud of. Each item is infused with CO2 extracted THC that is triple lab tested. Established in 2010 as allowed by Colorado House Bill 1284, Dixie Elixirs and Edibles manufactures seven premium THC-infused product lines: Dixie Elixirs Sparkling Beverages, Dixie Edibles, Dixie Dew Drops (sublingual tinctures), Dixie Scrips, Dixie Prime Connoisseur Concentrates, Dixie Topicals, and Dixie Synergy 1:1 CBD and THC formulated Dew Drops and Scrips. As the leader in medical marijuana-infused products, Dixie is proud to receive the first Infused Products Retail Marijuana License. | $8M / Venture - Series Unknown / Jun 01, 2014 | ||
| ACC has successfully procured licensing agreements for its clients in several states and is accessing existing and new growth opportunities, in both domestic and international cannabis markets. American Cannabis Company Inc. was Co-founded by Corey Hollister and Ellis Smith, former owners of The Village Green Society in Boulder, CO. They were thefirst to cultivate medical cannabis on a commercial scale using a niche growing technique known as True Living Organics (TLO) producing pharmaceutical grade cannabis products for the Colorado patient market. They received national recognition for this innovation, as well as for having helped the industry identify and develop mitigation protocols for new pest. To this we add a team of seasoned professionals from diverse industries such as healthcare, agriculture and construction and engineering. | Series A / May 01, 2014 | ||
| MassRoots is a social network technology platform for the cannabis consumers and community with over 900,000 users, 170 million user-to-user interactions, and 500 actively posting dispensaries. People use the MassRoots app on IOS and Android to find smoking buddies, share their cannabis experiences with like-minded friends, and stay connected withlocal dispensaries. MassRoots was founded under the belief that a future where humans can freely experience the positive effects of cannabis is fundamentally better than one in which they cannot. Today, MassRoots is actively fostering the community and developing the technologies to make this future a reality, with the ultimate goal of worldwide cannabis legalization. | $475K / Series A / Mar 26, 2014 | ||
| ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE® and Kids-EEZE® product lines. Our ongoing objective is to deliver long-term value by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments. | $7M / Post-IPO Equity / Jan 01, 2014 | ||
| The Coastal Compassion team is comprised of a small group of highly skilled professionals with varied disciplines from both inside and outside the MMJ industry. These varied backgrounds enable the Coastal Compassion team to focus on managing the various aspects of this highly regulated program in a patient centric way. | Seed / Nov 01, 2013 | ||
| iTalk, with its innovative technology, is spearheading a wireless revolution to lower communications costs and has targeted the $40 billion iPod accessory market and the $340 billion global cellular market. iTalk is combining the power of the internet and its proprietary technology to integrate nationwide connectivity and global communications into the iPod touch. iTalk’s low cost, no contract service will disrupt traditional wireless carriers by displacing antiquated technology requiring expensive cell phone plans and contracts. The increased power of today's handheld electronics has enabled iTalk to create innovations in cellular communications by integrating VoIP technology into mobile devices. | $250K / Post-IPO Debt / Oct 21, 2013 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Dutchess Opportunity Fund invest in?
Dutchess Opportunity Fund invests primarily in Cannabis, Health Care and Manufacturing startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dutchess Opportunity Fund last invest?
The most recent investment recorded for Dutchess Opportunity Fund closed in Jan 2015. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
